PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Wenjian Li

Xuzhou Medical College

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 1, 2026 · JOURNAL ARTICLE

Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges

International Journal of Nanomedicine

This is a narrative review synthesizing preclinical and early-stage work on nanoplatform design; it raises therapeutic and diagnostic opportunities but does not report a primary clinical trial result, efficacy comparison, or outcome data.

Hypothesis-GeneratingProstate Cancer Treatment and Research Nanoparticle-based Drug Delivery Wenjian Li

Reported

PSMA-negative expression in castr…15–37%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support